title: Antiplatelet therapy: glycoprotein IIb/IIIa receptor antagonists.
abstract: The glycoprotein IIb/IIIa antagonists are potent drugs that inhibit platelet aggregation. They are formulated as monoclonal antibodies and synthetic peptides for intravenous use in patients undergoing high-risk angioplasty procedures and in patients with unstable coronary syndromes. Orally active agents are now being evaluated in clinical trials.
authors.affiliation: Department of Medicine, New York Medical College, Valhalla 10595, USA.
authors.forename: S
authors.initials: S
authors.lastname: Kessler
authors.forename: D
authors.initials: D
authors.lastname: Kessler
authors.forename: W H
authors.initials: WH
authors.lastname: Frishman